A detailed history of Htlf Bank transactions in Abb Vie Inc. stock. As of the latest transaction made, Htlf Bank holds 31,330 shares of ABBV stock, worth $5.64 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
31,330
Previous 32,237 2.81%
Holding current value
$5.64 Million
Previous $5.53 Billion 11.9%
% of portfolio
0.67%
Previous 0.63%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $148,602 - $180,792
-907 Reduced 2.81%
31,330 $6.19 Billion
Q2 2024

Jul 23, 2024

SELL
$154.79 - $180.76 $210,669 - $246,014
-1,361 Reduced 4.05%
32,237 $5.53 Billion
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $174,683 - $199,035
-1,093 Reduced 3.15%
33,598 $6.12 Billion
Q4 2023

Jan 31, 2024

BUY
$137.6 - $154.97 $4.77 Million - $5.38 Million
34,691 New
34,691 $5.38 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Htlf Bank Portfolio

Follow Htlf Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Htlf Bank, based on Form 13F filings with the SEC.

News

Stay updated on Htlf Bank with notifications on news.